OMERのPER（株価収益率）は？

Omeros Corporation（OMER）は現在PER 6.38倍で取引されています。

OMERのROE（自己資本利益率）は？

Omeros CorporationのROEは-136.06%です。

OMERの配当利回りは？

Omeros Corporationの配当利回りは0.00%です。

OMERの品質スコア（Quality Score）は？

当社のAIはOMERの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

OMERは今が買い時ですか？

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

OMERはどのセクターに属しますか？

Omeros CorporationはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

OMER (NASDAQ) 株価分析 | OMEROS CORPORATION

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

OMER AI Analysis Summary

Our AI summary for OMER: Omeros Corporation (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 6.38, ROE of -136.06%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

OMER

Omeros Corporation

US:NASDAQ STOCK Healthcare >> Biotechnology News 82

USD 12.94

0.38 (3.03%) Day Change

Watchlist Portfolio Compare Chart

6.38

P/E

-2.58

D/E

-136.1%

ROE

30.1%

ROA

0.00%

Div Yield

-0.05

PEG

OMEROS CORPORATION
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 12.94 Price 0.38 (3.03%) Day Change	NEWS SCORE: 82

OMER, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	82
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	12.94
PBV / Sector	-14.35 / 44,022.72
Earning Per Share	1.23

PE / Sector	6.38 / 19.17 GREAT
PEG or PE/Growth / Sector	-0.05 / 1.24
Average 1M Daily Value	15.59 M GREAT
Average 1W Daily Value	17.97 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	871.02 / 98.24 GREAT
NPM Average (%) / Sector	871.02 / -1,697.63 GREAT
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	30.11 / 185,260.96 GREAT
ROA Average (%) / Sector	-10.13 / 36,684.70
ROA Change Average (%) / Sector	-882.89 / 422,221.66
ROE (%) / Sector	-136.06 / 243,762.23
ROE Average (%) / Sector	95.90 / 48,758.47 GREAT
ROE Change Average (%) / Sector	-1,112.52 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

登録情報

Analyze Date	2026-08-05 08:00:38
Symbol	OMER
Name	OMEROS CORPORATION
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	72.38 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	909.03 / 9,586.08

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: The Omeros Building, Seattle, WA, United States, 98119

Phone: 206 676 5000

Website: https://www.omeros.com

Employees: 175

Sector: Healthcare >> Biotechnology

Description: Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.